GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TMC Life Sciences Bhd (XKLS:0101) » Definitions » ROIC %

TMC Life Sciences Bhd (XKLS:0101) ROIC % : 6.56% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is TMC Life Sciences Bhd ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. TMC Life Sciences Bhd's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was 6.56%.

As of today (2024-05-21), TMC Life Sciences Bhd's WACC % is 6.67%. TMC Life Sciences Bhd's ROIC % is 6.18% (calculated using TTM income statement data). TMC Life Sciences Bhd earns returns that do not match up to its cost of capital. It will destroy value as it grows.


TMC Life Sciences Bhd ROIC % Historical Data

The historical data trend for TMC Life Sciences Bhd's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMC Life Sciences Bhd ROIC % Chart

TMC Life Sciences Bhd Annual Data
Trend May13 May14 May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.76 2.76 2.40 4.20 4.30

TMC Life Sciences Bhd Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.85 6.86 4.36 6.78 6.56

Competitive Comparison of TMC Life Sciences Bhd's ROIC %

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TMC Life Sciences Bhd's ROIC % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's ROIC % distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's ROIC % falls into.



TMC Life Sciences Bhd ROIC % Calculation

TMC Life Sciences Bhd's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Jun. 2023 is calculated as:

ROIC % (A: Jun. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Jun. 2022 ) + Invested Capital (A: Jun. 2023 ))/ count )
=42.954 * ( 1 - 3.99% )/( (954.295 + 964.813)/ 2 )
=41.2401354/959.554
=4.30 %

where

Invested Capital(A: Jun. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1132.85 - 64.291 - ( 138.864 - max(0, 90.282 - 204.546+138.864))
=954.295

TMC Life Sciences Bhd's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

ROIC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=83.276 * ( 1 - 26.2% )/( (938.194 + 936.184)/ 2 )
=61.457688/937.189
=6.56 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1187.559 - 78.451 - ( 181.212 - max(0, 96.133 - 267.047+181.212))
=938.194

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1191.303 - 79.207 - ( 190.337 - max(0, 96.978 - 272.89+190.337))
=936.184

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TMC Life Sciences Bhd  (XKLS:0101) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, TMC Life Sciences Bhd's WACC % is 6.67%. TMC Life Sciences Bhd's ROIC % is 6.18% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


TMC Life Sciences Bhd ROIC % Related Terms

Thank you for viewing the detailed overview of TMC Life Sciences Bhd's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


TMC Life Sciences Bhd (XKLS:0101) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.

TMC Life Sciences Bhd (XKLS:0101) Headlines

No Headlines